AG
CCXI

Aperio Group’s ChemoCentryx, Inc. CCXI Stock Holding History

Aperio Group’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.06M Sell
17,167
-1,496
-8% -$85.6K ﹤0.01% 1565
2020
Q3 		$1.02M Buy
18,663
+3,539
+23% +$191K ﹤0.01% 1433
2020
Q2 		$870K Buy
15,124
+3,780
+33% +$206K ﹤0.01% 1484
2020
Q1 		$456K Buy
11,344
+3,165
+39% +$134K ﹤0.01% 1700
2019
Q4 		$323K Sell
8,179
-6,352
-44% -$112K ﹤0.01% 2030
2019
Q3 		$99K Buy
14,531
+5,735
+65% +$43K ﹤0.01% 2241
2019
Q2 		$82K Buy
+8,796
New +$102K ﹤0.01% 2438
2014
Q3 		– Sell
-10,374
Closed -$61K – 1774
2014
Q2 		$61K Sell
10,374
-25,245
-71% -$142K ﹤0.01% 1706
2014
Q1 		$236K Buy
+35,619
New +$247K ﹤0.01% 1772
2013
Q4 		– Hold
0
– – – 1943

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Aperio Group's CCXI Position: Q4 2020 in Review

Aperio Group reduced its ChemoCentryx, Inc. (CCXI) stake by 8% in Q4 2020, selling an estimated $85.6K and leaving 17,167 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1565.

Aperio Group first reported a position in CCXI in Q1 2014 and has held it in 9 quarters since. 196 funds tracked by Wall St. Rank hold CCXI as of Q4 2020.

  • Aperio Group held 17,167 shares of ChemoCentryx, Inc. worth $1.06M as of Q4 2020.
  • Aperio Group sold 1,496 ChemoCentryx, Inc. shares in Q4 2020, an estimated $85.6K.
  • ChemoCentryx, Inc. made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1565 holding.
  • Aperio Group first reported a position in ChemoCentryx, Inc. in Q1 2014 and has held it in 9 quarters since.
  • 196 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.